Target Als Foundation Inc logo

Target Als Foundation Inc

NEW YORK, NY EIN: 81-0756743 Website

Target ALS Foundation Inc is a 501(c)(3) public charity based in New York City dedicated to accelerating research and discovery of effective treatments for amyotrophic lateral sclerosis (ALS). Founded in 2013, the organization operates through its Innovation Ecosystem model, which brings together leading scientists from academia and industry to collaborate on ALS research with unprecedented urgency and efficiency.

Financial Overview

From 2024 IRS Form 990-PF · View filing

Total Assets

$128.9M

-28.6% YoY

Annual Giving

$18.0M

+68.5% YoY

Grant Count

75

+59.6% YoY

Avg Grant Size

$241K

+5.6% YoY

Research compiled by Grantable AI from public sources. Last updated April 2026.

Mission & Focus Areas

Mission: Break down barriers to ALS research to find effective treatments. Target ALS unites academia, the pharma and biotech industry, government, venture capital, nonprofits, and the ALS community to overcome challenges that have historically hindered progress.

Vision: A world where Everyone Lives—where breakthroughs in ALS research lead to effective treatments that give those living with ALS and their families hope and a future they deserve.

Core Values:

  • Impatient Optimism: Driven by the urgency of ALS (typically 2-5 years from diagnosis) while remaining steadfastly optimistic that effective treatments are achievable
  • Deliberate Disruption: Challenging the status quo by uniting multidisciplinary teams, removing intellectual property restrictions, and providing minimal to no-cost resources globally with no strings attached
  • Radical Collaboration: Bringing together diverse voices across researchers, clinicians, industry, and the ALS community

Grantmaking

Target ALS has funded over 750 research grants totaling $80 million invested in ALS research. The organization reports that 58% of research consortia it has funded has led to drug discovery.

Ready to take the next step with Target Als Foundation Inc?

Geographic Focus

Where this funder awards grants

Target ALS funds research primarily in California, New York, and Massachusetts, with a global reach. The organization provides resources and data access worldwide with no strings attached.

Grant Distribution by State

23states
+15 more states

Cities

Ann ArborArlingtonAtlantaBaltimoreBethesdaBostonBurlingtonCambridgeCarlsbadChicagoClevelandCoral GablesGlastonburyHoustonIrvineJacksonvilleJupiterKansas CityLa JollaLos Angeles

Financial History

Multi-year comparison from IRS filings

As of 2023-2024:

  • Total Assets: $128,911,762 (2024)
  • Total Revenue: $79.6M (2023); $51,745,776 (2024)
  • Total Expenses: $15.9M (2023); $27,108,058 (2024)
  • Total Liabilities: $3.05M (2023)
  • Total Giving: $18,048,427 (2024)

Major Funding Source: Bloomberg Family Foundation provided $16,000,000 in general support

The organization maintains significant reserves relative to annual spending, positioning it to sustain long-term research initiatives.

Revenue
Expenses
Qualifying Distributions
Net Investment Income
$0$27M$54M$81M$108M20202021202220232024
Metric202420232022
Total Assets$128,911,762$180,572,961$115,562,468
Revenue$51,745,776$79,570,641$98,381,069
Expenses$27,108,058$15,859,537$9,271,989
Qualifying Distributions$27,030,939$15,856,237$9,271,989
Net Investment Income$3,765,775$407,954$24,092
Distributable Amount$3,680,524$7,785,698$4,423,430

Giving Over Time

Total grant dollars and number of grants per year

$0$5M$9M$14M$18M27 grants202025 grants202133 grants202247 grants202375 grants2024

Grant Insights

How this funder distributes its grants

Top Recipients

Top 10 recipients in 2024

NEW YORK GENOME CENTER$1.2MDIGNITY HEALTH - ST JOSE…$965KMASSACHUSETTS GENERAL HO…$670KJOHNS HOPKINS UNIVERSITY$580KSWISS FEDERAL INSTITUTE …$540KCOLUMBIA UNIVERSITY$517KN-LOREM FOUNDATION$500KEMORY UNIVERSITY$384KSTANFORD UNIVERSITY$382KTHE JACKSON LABORATORY$370K

Grant Size Distribution

182 grants across all recorded years

8<$50K31$50–100K97$100–250K28$250–500K16$500K–1M2$1–5M$5M+

Giving History

Grant recipients and amounts by year

No grants recorded for .

Leadership & Key People

Leadership team and compensation from IRS filings

Founder: Dan Doctoroff (founded Target ALS in 2013)

Staff Contact: Christine Aranyos Prouty (Wire transfer inquiries)

Compensation Overview

From 2024 IRS filing

MANISH RAISINGHANIPRESIDENT$400KKENNETH DEVANEYTREASURER$286K

From 2024 filing

NameTitleHoursCompensation
ALLISON JAFFINBOARD MEMBER1
ANDY BERNDTBOARD MEMBER1
CHRIS HENDERSONBOARD MEMBER1
MANISH RAISINGHANIPRESIDENT40$400,414
KENNETH DEVANEYTREASURER40$286,188
DANIEL L DOCTOROFFCHAIR1
JOHN DUNLOPBOARD MEMBER1
ZACH W HALLBOARD MEMBER1
STORY LANDISBOARD MEMBER1
RICHARD HARGEAVESBOARD MEMBER1
CAROLE HOBOARD MEMBER1
STACIE WENINGERBOARD MEMBER1
SARA SHEIKHBOARD MEMBER1
ALISA DOCTOROFFBOARD MEMBER1
BRAD S KARPBOARD MEMBER1

Recent News & Activity

Recent developments and announcements

Target ALS continues to expand its grantmaking portfolio with recent announcements including:

2025

2025 In Vivo Target Validation Grantees announced

Announcing the 2025 In Vivo Target Validation Grantees
2025

2025 Novel Modalities Consortia Grantees announced

Announcing the 2025 Novel Modalities Consortia Grantees

Third-year funding awarded to three groundbreaking projects pushing the frontier of ALS treatment

Target ALS Awards Third-Year Funding to Three Groundbreaking Projects Pushing
2026

Q1 2026 grants and funding opportunities update released

Q1 2026 Grants & Funding Opportunities Update - Target ALS

Grantee NRG Therapeutics advanced NRG5051 into Phase I clinical trial, representing progress toward viable treatments

Target ALS Grantee NRG Therapeutics Advances NRG5051 into ...

Contact Information

Address: 244 Madison Avenue #1025, New York, NY 10016

Phone: (332) 333-4140

Website: www.targetals.org

Giving Options: Target ALS accepts one-time donations, monthly gifts, tribute gifts, donor-advised fund recommendations, planned gifts, and corporate sponsorships. The organization also hosts an annual meeting bringing together over 900 global leaders in ALS research and innovation.

Subject Areas

Focus areas based on grantmaking activity

Related Funders

Similar funders by location and focus area

Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.

What could you do with Target Als Foundation Inc on Grantable?

  • Assess strategic fit with your organization
  • Draft a tailored letter of inquiry
  • Find open RFPs from this funder
  • Monitor for new funding opportunities